Smoking-related interstitial fibrosis (SRIF): Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
[[File:Srifhistology3.jpg|Histological image of SRIF | | name = Smoking-related interstitial fibrosis | ||
| image = [[File:Srifhistology3.jpg|250px]] | |||
| caption = Histological image of smoking-related interstitial fibrosis | |||
| synonyms = SRIF | |||
| specialty = [[Pulmonology]], [[Pathology]] | |||
| symptoms = [[Shortness of breath]], [[cough]], [[fatigue]] | |||
| complications = [[Pulmonary hypertension]], [[respiratory failure]] | |||
| onset = Typically in middle-aged to older adults | |||
| duration = Chronic | |||
| causes = [[Cigarette smoking]] | |||
| risks = Long-term [[tobacco use]] | |||
| diagnosis = [[Lung biopsy]], [[high-resolution computed tomography]] | |||
| differential = [[Idiopathic pulmonary fibrosis]], [[chronic obstructive pulmonary disease]] | |||
| prevention = [[Smoking cessation]] | |||
| treatment = [[Smoking cessation]], [[supportive care]] | |||
| prognosis = Variable, depends on extent of fibrosis and smoking cessation | |||
| frequency = Rare, but underrecognized | |||
}} | |||
'''Smoking-related interstitial fibrosis''' (SRIF) is a specific type of [[pulmonary fibrosis]] that is associated with [[cigarette smoking]]. It is characterized by the accumulation of dense collagen fibers in the interstitial spaces of the [[lung]], leading to impaired respiratory function. SRIF is considered a distinct pathological entity within the spectrum of smoking-related lung diseases. | '''Smoking-related interstitial fibrosis''' (SRIF) is a specific type of [[pulmonary fibrosis]] that is associated with [[cigarette smoking]]. It is characterized by the accumulation of dense collagen fibers in the interstitial spaces of the [[lung]], leading to impaired respiratory function. SRIF is considered a distinct pathological entity within the spectrum of smoking-related lung diseases. | ||
== Pathophysiology == | == Pathophysiology == | ||
The pathogenesis of SRIF involves chronic exposure to the harmful chemicals in cigarette smoke, which leads to repeated injury and inflammation of the lung parenchyma. Over time, this results in the activation of fibroblasts and excessive deposition of collagen in the interstitial spaces. The dense collagen fibers disrupt the normal architecture of the lung, leading to decreased lung compliance and impaired gas exchange. | The pathogenesis of SRIF involves chronic exposure to the harmful chemicals in cigarette smoke, which leads to repeated injury and inflammation of the lung parenchyma. Over time, this results in the activation of fibroblasts and excessive deposition of collagen in the interstitial spaces. The dense collagen fibers disrupt the normal architecture of the lung, leading to decreased lung compliance and impaired gas exchange. | ||
== Clinical Presentation == | == Clinical Presentation == | ||
Patients with SRIF may present with symptoms such as chronic cough, dyspnea (shortness of breath), and reduced exercise tolerance. These symptoms are often insidious in onset and may be mistaken for other smoking-related conditions such as [[chronic obstructive pulmonary disease]] (COPD) or [[emphysema]]. | Patients with SRIF may present with symptoms such as chronic cough, dyspnea (shortness of breath), and reduced exercise tolerance. These symptoms are often insidious in onset and may be mistaken for other smoking-related conditions such as [[chronic obstructive pulmonary disease]] (COPD) or [[emphysema]]. | ||
== Diagnosis == | == Diagnosis == | ||
The diagnosis of SRIF is primarily based on histological examination of lung tissue obtained via [[lung biopsy]]. The characteristic finding is the presence of dense, eosinophilic collagen bundles in the interstitial spaces, often with minimal associated inflammation. High-resolution [[computed tomography]] (HRCT) of the chest may show reticular opacities and interstitial thickening, but these findings are not specific to SRIF. | The diagnosis of SRIF is primarily based on histological examination of lung tissue obtained via [[lung biopsy]]. The characteristic finding is the presence of dense, eosinophilic collagen bundles in the interstitial spaces, often with minimal associated inflammation. High-resolution [[computed tomography]] (HRCT) of the chest may show reticular opacities and interstitial thickening, but these findings are not specific to SRIF. | ||
== Treatment == | == Treatment == | ||
Currently, there is no specific treatment for SRIF. Management focuses on smoking cessation and supportive care to alleviate symptoms. Pulmonary rehabilitation and oxygen therapy may be beneficial for some patients. The progression of fibrosis may stabilize with smoking cessation, but the existing fibrosis is generally irreversible. | Currently, there is no specific treatment for SRIF. Management focuses on smoking cessation and supportive care to alleviate symptoms. Pulmonary rehabilitation and oxygen therapy may be beneficial for some patients. The progression of fibrosis may stabilize with smoking cessation, but the existing fibrosis is generally irreversible. | ||
== Prognosis == | == Prognosis == | ||
The prognosis of SRIF varies depending on the extent of fibrosis and the presence of other smoking-related lung diseases. In general, the condition is slowly progressive, and the degree of functional impairment correlates with the extent of fibrosis. Smoking cessation is crucial in preventing further lung damage. | The prognosis of SRIF varies depending on the extent of fibrosis and the presence of other smoking-related lung diseases. In general, the condition is slowly progressive, and the degree of functional impairment correlates with the extent of fibrosis. Smoking cessation is crucial in preventing further lung damage. | ||
== See Also == | |||
== | |||
* [[Pulmonary fibrosis]] | * [[Pulmonary fibrosis]] | ||
* [[Chronic obstructive pulmonary disease]] | * [[Chronic obstructive pulmonary disease]] | ||
* [[Emphysema]] | * [[Emphysema]] | ||
* [[Lung biopsy]] | * [[Lung biopsy]] | ||
[[Category:Pulmonary diseases]] | [[Category:Pulmonary diseases]] | ||
[[Category:Smoking-related diseases]] | [[Category:Smoking-related diseases]] | ||
Latest revision as of 05:58, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Smoking-related interstitial fibrosis | |
|---|---|
| |
| Synonyms | SRIF |
| Pronounce | N/A |
| Specialty | Pulmonology, Pathology |
| Symptoms | Shortness of breath, cough, fatigue |
| Complications | Pulmonary hypertension, respiratory failure |
| Onset | Typically in middle-aged to older adults |
| Duration | Chronic |
| Types | N/A |
| Causes | Cigarette smoking |
| Risks | Long-term tobacco use |
| Diagnosis | Lung biopsy, high-resolution computed tomography |
| Differential diagnosis | Idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease |
| Prevention | Smoking cessation |
| Treatment | Smoking cessation, supportive care |
| Medication | N/A |
| Prognosis | Variable, depends on extent of fibrosis and smoking cessation |
| Frequency | Rare, but underrecognized |
| Deaths | N/A |
Smoking-related interstitial fibrosis (SRIF) is a specific type of pulmonary fibrosis that is associated with cigarette smoking. It is characterized by the accumulation of dense collagen fibers in the interstitial spaces of the lung, leading to impaired respiratory function. SRIF is considered a distinct pathological entity within the spectrum of smoking-related lung diseases.
Pathophysiology[edit]
The pathogenesis of SRIF involves chronic exposure to the harmful chemicals in cigarette smoke, which leads to repeated injury and inflammation of the lung parenchyma. Over time, this results in the activation of fibroblasts and excessive deposition of collagen in the interstitial spaces. The dense collagen fibers disrupt the normal architecture of the lung, leading to decreased lung compliance and impaired gas exchange.
Clinical Presentation[edit]
Patients with SRIF may present with symptoms such as chronic cough, dyspnea (shortness of breath), and reduced exercise tolerance. These symptoms are often insidious in onset and may be mistaken for other smoking-related conditions such as chronic obstructive pulmonary disease (COPD) or emphysema.
Diagnosis[edit]
The diagnosis of SRIF is primarily based on histological examination of lung tissue obtained via lung biopsy. The characteristic finding is the presence of dense, eosinophilic collagen bundles in the interstitial spaces, often with minimal associated inflammation. High-resolution computed tomography (HRCT) of the chest may show reticular opacities and interstitial thickening, but these findings are not specific to SRIF.
Treatment[edit]
Currently, there is no specific treatment for SRIF. Management focuses on smoking cessation and supportive care to alleviate symptoms. Pulmonary rehabilitation and oxygen therapy may be beneficial for some patients. The progression of fibrosis may stabilize with smoking cessation, but the existing fibrosis is generally irreversible.
Prognosis[edit]
The prognosis of SRIF varies depending on the extent of fibrosis and the presence of other smoking-related lung diseases. In general, the condition is slowly progressive, and the degree of functional impairment correlates with the extent of fibrosis. Smoking cessation is crucial in preventing further lung damage.
